4.6 Article

Treatment of Nelson's syndrome with temozolomide

Journal

EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 160, Issue 1, Pages 115-119

Publisher

BIOSCIENTIFICA LTD
DOI: 10.1530/EJE-08-0557

Keywords

-

Ask authors/readers for more resources

A 64-year-old woman was previously treated for Cushing's disease with trans-sphenoidal surgery, external beam radiotherapy and bilateral adrenalectomy. Progression of an aggressive corticotroph adenoma was evident 3 years post-adrenalectomy; involvement of the clivus was treated With Surgery and gamma knife radiosurgery. Tumour spread through the skull base, occiput and left car with persistent facial pain and left car discharge; progression continued despite second gamma knife treatment. ACTII levels peaked at 2472 and 2265 pmol/l pre- and post-hydrocortisone respectively. Treatment with temozolomide resulted in a significant improvement in symptoms, a reduction of plasma ACTH to 389 pmol/l and regression or tumour on magnetic resonance imaging scan after four cycles of treatment. We propose that. temozolomide is an effective and well-tolerated therapeutic tool for the treatment of Nelson's syndrome and a useful addition to the range of therapies available to treat this condition.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available